The global equine influenza vaccine market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Equine influenza is a highly contagious respiratory disease. It occurs in horses and other Equidae that is caused by two subtypes of the influenza A virus of the Orthomyxoviridae family including H7N7 and H3N8. The major factor for the growth of the market is the rising initiatives and growing concern from government and animal healthcare organizations for the well-being of the animals.  

Additionally, the virus is spread by coming in contact with infected animals. Furthermore, the virus can also spread by mechanical transmission clothing, equipment, brushes, among others which are carried by people working with horses. Some major players in the market include Merck & Co., Inc., Boehringer Ingelheim GmbH, and Zoetis Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in May 2018, Merck Animal Health announced the availability of the next generation of influenza-containing vaccines. It is offered under the company’s PRESTIGE line of vaccines for the treatment of horses. 

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segment Covered- 

o By Vaccine Type

o By End-Users

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

    • Competitive Landscape- Merck & Co., Inc., Boehringer Ingelheim GmbH, and Zoetis Inc., among others.

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How players are addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Equine Influenza Vaccine Market Report by Segment

By Vaccine Type 

    • Powder 

    • Dry

By End-Users 

    • Home

    • Pet Clinic

    • Others

Global Equine Influenza Vaccine Market Report by Region

North America

    • United States

    • Canada

Europe

    • UK

    • Germany

    • Italy

    • Spain

    • France

    • Rest of Europe 

Asia-Pacific

    • China

    • India

    • Japan

    • South Korea

    • Rest of Asia-Pacific 

Rest of the World

    • Latin America 

    • Middle East & Africa